These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Choroidal melanoma: a review of the experience of the Sydney Eye Hospital Professorial Unit 1979-1995. Reader S; Grigg J; Billson FA Aust N Z J Ophthalmol; 1997 Feb; 25(1):15-24. PubMed ID: 9107391 [TBL] [Abstract][Full Text] [Related]
28. Quality of life assessment in the collaborative ocular melanoma study: design and methods. COMS-QOLS Report No. 1. COMS Quality of Life Study Group. Ophthalmic Epidemiol; 1999 Mar; 6(1):5-17. PubMed ID: 10384680 [TBL] [Abstract][Full Text] [Related]
29. Design and methods of a clinical trial for a rare condition: the Collaborative Ocular Melanoma Study. COMS Report No. 3. Control Clin Trials; 1993 Oct; 14(5):362-91. PubMed ID: 8222668 [TBL] [Abstract][Full Text] [Related]
30. Outcomes of iodine 125 plaque radiotherapy after initial observation of suspected small choroidal melanomas: a pilot study. Sobrin L; Schiffman JC; Markoe AM; Murray TG Ophthalmology; 2005 Oct; 112(10):1777-83. PubMed ID: 16095708 [TBL] [Abstract][Full Text] [Related]
31. Outcomes of choroidal melanomas treated with eye physics: a 20-year review. Berry JL; Dandapani SV; Stevanovic M; Lee TC; Astrahan M; Murphree AL; Kim JW JAMA Ophthalmol; 2013 Nov; 131(11):1435-42. PubMed ID: 24008431 [TBL] [Abstract][Full Text] [Related]
32. Development and validation of disease-specific measures for choroidal melanoma: COMS-QOLS report No. 2. Melia M; Moy CS; Reynolds SM; Cella D; Murray TG; Hovland KR; Hayman JA; Mangione CM; Arch Ophthalmol; 2003 Jul; 121(7):1010-20. PubMed ID: 12860806 [TBL] [Abstract][Full Text] [Related]
34. Mortality after deferral of treatment or no treatment for choroidal melanoma. Straatsma BR; Diener-West M; Caldwell R; Engstrom RE; Indian J Ophthalmol; 2018 Oct; 66(10):1395-1400. PubMed ID: 30249822 [TBL] [Abstract][Full Text] [Related]
35. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas. Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534 [TBL] [Abstract][Full Text] [Related]
36. Endoresection versus iodine-125 plaque brachytherapy for the treatment of choroidal melanoma. Caminal JM; Mejia K; Masuet-Aumatell C; Arias L; Piulats JM; Gutierrez C; Pera J; Catala J; Rubio M; Arruga J Am J Ophthalmol; 2013 Aug; 156(2):334-342.e1. PubMed ID: 23677135 [TBL] [Abstract][Full Text] [Related]
37. The Collaborative Ocular Melanoma Study: an overview. Margo CE Cancer Control; 2004; 11(5):304-9. PubMed ID: 15377989 [TBL] [Abstract][Full Text] [Related]
38. Factors predictive of growth and treatment of small choroidal melanoma: COMS Report No. 5. The Collaborative Ocular Melanoma Study Group. Arch Ophthalmol; 1997 Dec; 115(12):1537-44. PubMed ID: 9400787 [TBL] [Abstract][Full Text] [Related]
39. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma III: local complications and observations following enucleation COMS report no. 11. Am J Ophthalmol; 1998 Sep; 126(3):362-72. PubMed ID: 9744369 [TBL] [Abstract][Full Text] [Related]
40. Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: dose and dose rate effects. Jones R; Gore E; Mieler W; Murray K; Gillin M; Albano K; Erickson B Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):989-95. PubMed ID: 11958893 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]